Frontiers | Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association
Identification of Genetic Causes of Focal Segmental Glomerulosclerosis Increases With Proper Patient Selection - Mayo Clinic Proceedings
Edgar V. Lerma 🇵🇭 on Twitter: "Treatment of Minimal Change Disease (MCD)/ Focal Segmental Glomerulosclerosis (FSGS) ca. 2019 from @goKDIGO #NephJC #Nephpearls 👉🏼 https://t.co/aiG2KkeCde https://t.co/NxqCVmveVu" / Twitter
Focal Segmental Glomerulosclerosis (FSGS) – AAKP
Treatment recommendations for children with FSGS | Download Table
January 2020 | Case of the Month Answer for Residency Program | UC Davis Department of Pathology
Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors | Nefrología
Frontiers | Collapsing Glomerulopathy: A Review by the Collapsing Brazilian Consortium
Focal Segmental Glomerulosclerosis Market 2021 Top 10 Global Players Introducing Future Opportunities and Demand by 2027 – GlaxoSmithKline plc., Novartis AG, AbbVie, Inc., Pfizer, Inc., Sanofi S.A | Medgadget
How to Treat Corticosteroid-Resistant Idiopathic Focal Segmental Glomerulosclerosis? | Nefrología
Immune-mediated entities of (primary) focal segmental glomerulosclerosis | SpringerLink
PDF] Optimal management of primary focal segmental glomerulosclerosis in adults | Semantic Scholar
Focal Segmental Glomerulosclerosis (FSGS) - NephCure Kidney International ®
Clinical manifestations of focal segmental glomerulosclerosis in Japan from the Japan Renal Biopsy Registry: age stratification and comparison with minimal change disease | Scientific Reports
Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial - ScienceDirect
Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal | SpringerLink